The diaspora vote count is continuing, VV achieves the 53rd term, PDK remains at 22, LDK falls to 18
2 hours agoTest of the vaccine, of AstraZeneca and Oxford: Doubtful Reaction to a Sharer
Periskopi(6 years ago)
(6 years ago)When the whole world is waiting for a vaccine against Ovid 19, and when hundreds of companies have started testing, it seems we should wait longer for a final answer. Clinical trials for a coronary vaccine, which is being conducted by the AstraZeneca non-company and Oxford University, have been temporarily interrupted as a participant [...]
Clinical trials for a coronary vaccine, which The Astra-Zeneca campaign and Oxford University are under way, temporarily interrupted as suspicious reactions contrary to expected were seen to a British participant. It's not yet known what happened, but the participant is recovering.
AstraZeneca described as a “ruin” respited in the case of “an inexplicable disease”.
According to a company spokesman “The standard revision process caused the vaccine pause to allow safer revision of the data. Vaccina AstraZeneca-Oxford University is seen as a strong contender among dozens of vaccines developing globally.
It has already passed the first two trials, the third phase of the trial has included 30,000 participants from the US, Britain, Brazil, South Africa. The third phase of a Vakisne usually includes thousands of participants and may last several years.
The nine main developers of US and European vaccines pledged to maintain scientific safety and efficiency standards for their experimental vaccines, despite the urgency of preventing the coronary pandemic.
Companies, including AstraZeneca, Pfizer Inc and GlaxosSmithKline, published what they called a <x0) historical prism” following an increase in concern that safety standards can be bypassed before political pressure to have a vaccine.
Companies said they “would support the integrity of the scientific process while working towards possible global regulatory records and approvals of the first vaccines of COVID-19”. The other signatories were Johnson & Johnson, Merck & Co, Modernna Inc, Novavax Inc, Sanofi and BioNTech.
